What to expect when you take Cephalexin and have Bowel obstruction?

Do you take Cephalexin and have Bowel obstruction? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Apr, 22, 2018

3,146 reports have been studied.


Females aged 50 to 59 :

2,026 related reports were analyzed:

Most common symptoms:

  • Abdominal pain
    • 7.16% for females aged 50 (±5) who take Cephalexin
  • Anaemia (lack of blood)
    • 11.75% for females aged 50 (±5) who take Cephalexin
  • Anhedonia (inability to experience pleasure from activities usually found enjoyable)
    • 5.43% for females aged 50 (±5) who take Cephalexin
  • Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat)
    • 5.97% for females aged 50 (±5) who take Cephalexin
  • Back pain
    • 12.24% for females aged 50 (±5) who take Cephalexin
  • Bone disorder
    • 9.92% for females aged 50 (±5) who take Cephalexin
  • Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
    • 5.13% for females aged 50 (±5) who take Cephalexin
  • Bone pain
    • 6.27% for females aged 50 (±5) who take Cephalexin
  • Cellulitis (infection under the skin)
    • 8.34% for females aged 50 (±5) who take Cephalexin
  • Chest pain
    • 7.8% for females aged 50 (±5) who take Cephalexin
  • Constipation
    • 6.86% for females aged 50 (±5) who take Cephalexin
  • Cough
    • 6.17% for females aged 50 (±5) who take Cephalexin
  • Deformity (disfigurement)
    • 5.53% for females aged 50 (±5) who take Cephalexin
  • Dehydration (dryness resulting from the removal of water)
    • 5.73% for females aged 50 (±5) who take Cephalexin
  • Depression
    • 10.71% for females aged 50 (±5) who take Cephalexin
  • Diarrhea
    • 11.94% for females aged 50 (±5) who take Cephalexin
  • Dizziness
    • 9.67% for females aged 50 (±5) who take Cephalexin
  • Drug hypersensitivity
    • 6.42% for females aged 50 (±5) who take Cephalexin
  • Dyspnea (difficult or laboured breathing)
    • 12.19% for females aged 50 (±5) who take Cephalexin
  • Emotional distress
    • 9.08% for females aged 50 (±5) who take Cephalexin
  • Exostosis (formation of new bone on the surface of a bone)
    • 6.17% for females aged 50 (±5) who take Cephalexin
  • Fall
    • 9.87% for females aged 50 (±5) who take Cephalexin
  • Fatigue (feeling of tiredness)
    • 12.54% for females aged 50 (±5) who take Cephalexin
  • Fever
    • 10.86% for females aged 50 (±5) who take Cephalexin
  • Gait disturbance
    • 6.52% for females aged 50 (±5) who take Cephalexin
  • Gastroesophageal reflux disease (a condition in which stomach contents leak backward from the stomach into the oesophagus)
    • 8.88% for females aged 50 (±5) who take Cephalexin
  • Headache (pain in head)
    • 9.28% for females aged 50 (±5) who take Cephalexin
  • High blood pressure
    • 8.09% for females aged 50 (±5) who take Cephalexin
  • Hypoaesthesia (reduced sense of touch or sensation)
    • 11.85% for females aged 50 (±5) who take Cephalexin
  • Impaired healing
    • 5.48% for females aged 50 (±5) who take Cephalexin
  • Injury
    • 10.86% for females aged 50 (±5) who take Cephalexin
  • Insomnia (sleeplessness)
    • 6.91% for females aged 50 (±5) who take Cephalexin
  • Intervertebral disc protrusion (spinal disc protrusion)
    • 6.61% for females aged 50 (±5) who take Cephalexin
  • Joint pain
    • 11.45% for females aged 50 (±5) who take Cephalexin
  • Metastases to bone (cancer spreads to bone)
    • 6.86% for females aged 50 (±5) who take Cephalexin
  • Nausea (feeling of having an urge to vomit)
    • 15.4% for females aged 50 (±5) who take Cephalexin
  • Nausea and vomiting
    • 8.59% for females aged 50 (±5) who take Cephalexin
  • Neuropathy peripheral (surface nerve damage)
    • 7.7% for females aged 50 (±5) who take Cephalexin
  • Oedema peripheral (superficial swelling)
    • 8.64% for females aged 50 (±5) who take Cephalexin
  • Osteoarthritis (a joint disease caused by cartilage loss in a joint)
    • 10.81% for females aged 50 (±5) who take Cephalexin
  • Osteomyelitis (infection of bone)
    • 6.17% for females aged 50 (±5) who take Cephalexin
  • Osteonecrosis of jaw (death of bone of jaw)
    • 11.9% for females aged 50 (±5) who take Cephalexin
  • Osteoporosis (bones weak and more likely to break)
    • 6.12% for females aged 50 (±5) who take Cephalexin
  • Pain
    • 20.34% for females aged 50 (±5) who take Cephalexin
  • Pain in extremity
    • 10.71% for females aged 50 (±5) who take Cephalexin
  • Pain in jaw
    • 7.45% for females aged 50 (±5) who take Cephalexin
  • Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
    • 7.6% for females aged 50 (±5) who take Cephalexin
  • Pleural effusion (water on the lungs)
    • 5.73% for females aged 50 (±5) who take Cephalexin
  • Pneumonia
    • 7.7% for females aged 50 (±5) who take Cephalexin
  • Rashes (redness)
    • 9.38% for females aged 50 (±5) who take Cephalexin
  • Sinusitis (inflammation of sinus)
    • 5.53% for females aged 50 (±5) who take Cephalexin
  • Spinal osteoarthritis (joint cartilage loss in spine)
    • 8.05% for females aged 50 (±5) who take Cephalexin
  • Stress and anxiety
    • 19.79% for females aged 50 (±5) who take Cephalexin
  • Swallowing difficulty
    • 6.86% for females aged 50 (±5) who take Cephalexin
  • Swelling
    • 6.76% for females aged 50 (±5) who take Cephalexin
  • Tooth abscess (pus formation in tooth)
    • 7.06% for females aged 50 (±5) who take Cephalexin
  • Tooth extraction
    • 5.33% for females aged 50 (±5) who take Cephalexin
  • Tooth loss
    • 7.35% for females aged 50 (±5) who take Cephalexin
  • Urinary tract infection
    • 9.03% for females aged 50 (±5) who take Cephalexin
  • Weakness
    • 13.18% for females aged 50 (±5) who take Cephalexin
  • Weight decreased
    • 7.01% for females aged 50 (±5) who take Cephalexin

Most common co-existing conditions:

  • Breast cancer
    • 6.02% for females aged 50 (±5) who take Cephalexin
  • Depression
    • 5.77% for females aged 50 (±5) who take Cephalexin
  • High blood pressure
    • 6.47% for females aged 50 (±5) who take Cephalexin
  • Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
    • 5.48% for females aged 50 (±5) who take Cephalexin
  • Pain
    • 8.34% for females aged 50 (±5) who take Cephalexin
  • Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
    • 6.02% for females aged 50 (±5) who take Cephalexin

Males aged 50 to 59 :

1,120 related reports were analyzed:

Most common symptoms:

  • Anaemia (lack of blood)
    • 6.43% for males aged 50 (±5) who take Cephalexin
  • Atelectasis (partial or complete collapse of the lung)
    • 5.18% for males aged 50 (±5) who take Cephalexin
  • Back pain
    • 6.88% for males aged 50 (±5) who take Cephalexin
  • Bone disorder
    • 5.8% for males aged 50 (±5) who take Cephalexin
  • Cellulitis (infection under the skin)
    • 8.48% for males aged 50 (±5) who take Cephalexin
  • Chest pain
    • 6.7% for males aged 50 (±5) who take Cephalexin
  • Constipation
    • 5.0% for males aged 50 (±5) who take Cephalexin
  • Cough
    • 5.63% for males aged 50 (±5) who take Cephalexin
  • Dehydration (dryness resulting from the removal of water)
    • 5.71% for males aged 50 (±5) who take Cephalexin
  • Depression
    • 9.02% for males aged 50 (±5) who take Cephalexin
  • Diarrhea
    • 6.07% for males aged 50 (±5) who take Cephalexin
  • Dizziness
    • 5.98% for males aged 50 (±5) who take Cephalexin
  • Dyspnea (difficult or laboured breathing)
    • 7.68% for males aged 50 (±5) who take Cephalexin
  • Fall
    • 5.45% for males aged 50 (±5) who take Cephalexin
  • Fatigue (feeling of tiredness)
    • 12.32% for males aged 50 (±5) who take Cephalexin
  • Fever
    • 8.48% for males aged 50 (±5) who take Cephalexin
  • Gastroesophageal reflux disease (a condition in which stomach contents leak backward from the stomach into the oesophagus)
    • 6.79% for males aged 50 (±5) who take Cephalexin
  • Headache (pain in head)
    • 7.32% for males aged 50 (±5) who take Cephalexin
  • High blood pressure
    • 7.14% for males aged 50 (±5) who take Cephalexin
  • Injury
    • 7.77% for males aged 50 (±5) who take Cephalexin
  • Insomnia (sleeplessness)
    • 6.52% for males aged 50 (±5) who take Cephalexin
  • Itching
    • 6.07% for males aged 50 (±5) who take Cephalexin
  • Joint pain
    • 7.05% for males aged 50 (±5) who take Cephalexin
  • Nausea (feeling of having an urge to vomit)
    • 10.36% for males aged 50 (±5) who take Cephalexin
  • Nausea and vomiting
    • 7.32% for males aged 50 (±5) who take Cephalexin
  • Oedema (fluid collection in tissue)
    • 5.09% for males aged 50 (±5) who take Cephalexin
  • Oedema peripheral (superficial swelling)
    • 6.88% for males aged 50 (±5) who take Cephalexin
  • Osteomyelitis (infection of bone)
    • 5.0% for males aged 50 (±5) who take Cephalexin
  • Osteonecrosis of jaw (death of bone of jaw)
    • 5.98% for males aged 50 (±5) who take Cephalexin
  • Pain
    • 14.2% for males aged 50 (±5) who take Cephalexin
  • Pain in extremity
    • 5.36% for males aged 50 (±5) who take Cephalexin
  • Pleural effusion (water on the lungs)
    • 6.16% for males aged 50 (±5) who take Cephalexin
  • Pneumonia
    • 5.45% for males aged 50 (±5) who take Cephalexin
  • Rashes (redness)
    • 10.18% for males aged 50 (±5) who take Cephalexin
  • Stress and anxiety
    • 16.25% for males aged 50 (±5) who take Cephalexin
  • Thrombocytopenia (decrease of platelets in blood)
    • 5.18% for males aged 50 (±5) who take Cephalexin
  • Weakness
    • 8.21% for males aged 50 (±5) who take Cephalexin
  • Weight decreased
    • 5.0% for males aged 50 (±5) who take Cephalexin

Most common co-existing conditions:

  • High blood pressure
    • 6.7% for males aged 50 (±5) who take Cephalexin
  • Pain
    • 7.86% for males aged 50 (±5) who take Cephalexin

Related tests

We suggest these affordable tests for self monitoring. You can order them and receive results on eHealthMe. No doctor referral or insurance necessary.

Related studies

cephalexin

Cephalexin has active ingredients of cephalexin. It is often used in infection. (latest outcomes from Cephalexin 12,233 users)

bowel obstruction

Bowel obstruction has been reported by people with crohn's disease, acne, high blood pressure, pain (latest reports from 28,514 Bowel obstruction patients).

Cephalexin and Bowel obstruction

Related publications that referenced our studies


Analysis tools (to study 684 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

Can you answer these questions

More questions for: Cephalexin, Bowel obstruction

You may be interested in these posts

More posts for: Cephalexin, Bowel obstruction

Recent updates

General studies
Active Support Groups
Recent Predictions
Personalized studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.